Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

143
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
143
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

253
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
253
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

93
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
93
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

176
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
176
Stages of General Anesthesia01:22

Stages of General Anesthesia

349
Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
349
Sedatives and Hypnotics Drugs: Barbiturates01:20

Sedatives and Hypnotics Drugs: Barbiturates

189
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
189

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomized Double-Blinded Clinical Trial of Oxytocin Bolus versus Infusion in Elective Cesarean (INBOX Trial).

Anesthesia and analgesia·2026
Same author

Mesenchymal Stem Cell Therapy for Neurological Complications of Prematurity: A Narrative Review.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Stroke Rehabilitation, Novel Technology and the Internet of Medical Things.

Brain sciences·2026
Same author

Pathophysiology and Management of Placenta Accreta Spectrum.

Journal of developmental biology·2025
Same author

Fifth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting: Executive Summary.

Anesthesia and analgesia·2025
Same author

Perioperative acute kidney injury: current prevention, detection, and management strategies.

Journal of anesthesia·2025

Related Experiment Video

Updated: May 28, 2025

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

19.6K

Evaluating Remimazolam for Procedural Sedation.

Genevieve Monanian1, Brandon Yonel1, Deborah Rupert2

  • 1Department of Anesthesiology, Stony Brook University Health Science Center, Stony Brook, NY, 11794-8480, USA.

Current Neuropharmacology
|February 12, 2025
PubMed
Summary

Remimazolam, a novel ultra-short-acting benzodiazepine, offers effective procedural sedation. Its rapid onset, recovery, and organ-independent metabolism make it a promising option for various medical procedures.

Keywords:
Remimazolamanalgesic propertiesclinical trialsdepressed consciousness.procedural sedationremimazolam

More Related Videos

Equipment Setup and Artifact Removal for Simultaneous Electroencephalogram and Functional Magnetic Resonance Imaging for Clinical Review in Epilepsy
10:23

Equipment Setup and Artifact Removal for Simultaneous Electroencephalogram and Functional Magnetic Resonance Imaging for Clinical Review in Epilepsy

Published on: June 23, 2023

1.8K
Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
08:49

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention

Published on: October 16, 2013

13.6K

Related Experiment Videos

Last Updated: May 28, 2025

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

19.6K
Equipment Setup and Artifact Removal for Simultaneous Electroencephalogram and Functional Magnetic Resonance Imaging for Clinical Review in Epilepsy
10:23

Equipment Setup and Artifact Removal for Simultaneous Electroencephalogram and Functional Magnetic Resonance Imaging for Clinical Review in Epilepsy

Published on: June 23, 2023

1.8K
Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
08:49

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention

Published on: October 16, 2013

13.6K

Area of Science:

  • Pharmacology
  • Anesthesiology
  • Clinical Medicine

Background:

  • Procedural sedation requires medications with anesthetic and analgesic properties.
  • Non-operating room anesthetizing locations present unique challenges for sedation management.
  • Remimazolam is a new ultra-short-acting benzodiazepine with potential for procedural sedation.

Purpose of the Study:

  • To review the current literature on the utility of remimazolam for procedural sedation.
  • To evaluate the efficacy and safety profile of remimazolam in clinical trials.
  • To discuss the pharmacokinetic and pharmacodynamic properties of remimazolam.

Main Methods:

  • Literature review of clinical trials and relevant studies on remimazolam.
  • Analysis of pharmacokinetic data, including metabolism and recovery times.
  • Assessment of efficacy and safety outcomes in procedural sedation settings.

Main Results:

  • Remimazolam demonstrates rapid onset and recovery, facilitating efficient procedural workflows.
  • Organ-independent metabolism of remimazolam simplifies its use in patients with hepatic or renal impairment.
  • Clinical trials indicate efficacy of remimazolam for achieving and maintaining desired sedation levels.

Conclusions:

  • Remimazolam is a viable and effective option for procedural sedation.
  • Its pharmacokinetic profile and clinical efficacy support its use in diverse medical settings.
  • Further research may elucidate its role in various procedural interventions.